WONDERLAB Appears at CHRO 2024, Drawing International Experts’ Attention to Its Evidence-Based Research

The 22nd International Workshop on Campylobacter, Helicobacter and Related Organisms (CHRO 2024) was held in Perth, Australia, from October 7 to 9. Professor Barry Marshall, a 2005 Nobel Prize laureate, chaired the event. The workshop brought together leading scientists, researchers and clinical experts from 26 countries and regions to discuss the effects of Campylobacter, *Helicobacter pylori* and other microorganisms on human and animal health.

Image 1. The 22nd International Workshop on Campylobacter, Helicobacter and Related Organisms

WONDERLAB was invited to participate in this internationally recognized academic meeting on microbiology research, where it joined prominent researchers from China and abroad in discussing evidence-based standards for probiotic R&D. At the exhibition, Professor Barry Marshall visited the WONDERLAB booth to experience Probiotics for Kids and All-in-One Probiotics. He also held an in-depth exchange with WONDERLAB on the potential health benefits of probiotics. As a brand from China, WONDERLAB was warmly received by international professionals attending the event.

Image 2. Professor Barry Marshall experiences WONDERLAB products and exchanges views at the WONDERLAB booth

WONDERLAB has consistently followed an evidence-based approach to product research, development and innovation. Its recent appearances at major clinical and microbiology research conferences in China and abroad reflect the company’s commitment to deeper participation in microbiology-related clinical research and to advancing the field of gut health. Going forward, WONDERLAB plans to strengthen collaboration in the medical field, continue following international frontiers in microbiology and contribute to research and development in the probiotic industry.